bluebird bio, Inc. is a company in the U.S. stock market and it is a holding in 65 U.S.-traded ETFs. BLUE has around 5.5M shares in the U.S. ETF market. The largest ETF holder of BLUE is the First Trust NYSE Arca Biotechnology Index Fund (FBT), with approximately 1.17M shares. Investors may also find of interest that the ETF with the largest allocation to BLUE stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 3.62%. On average, U.S. ETFs allocate 0.37% of BLUE to their portfolios.
Additionally, BLUE is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BLUE as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.